These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13497793)

  • 1. Renal damage in rats from the lead salt of EDTA and from umbradil.
    IVEMARK B; SELDINGER SI
    Acta radiol; 1957 Nov; 48(5):366-75. PubMed ID: 13497793
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic allergy to EDTA in local anesthetic and radiocontrast media.
    Russo PA; Banovic T; Wiese MD; Whyte AF; Smith WB
    J Allergy Clin Immunol Pract; 2014; 2(2):225-9. PubMed ID: 24607055
    [No Abstract]   [Full Text] [Related]  

  • 3. Chelation in contrast roentgenography with special reference to lead disodium edta.
    SHAPIRO R
    Am J Roentgenol Radium Ther Nucl Med; 1956 Jul; 76(1):161-7. PubMed ID: 13327146
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of EDTA calcium disodium on experimental metal poisoning. I. Effect of EDTA calcium disodium on the precipitation of manganese in experimental manganese poisoning in rats].
    SYKORA J; EYBL V
    Arch Int Pharmacodyn Ther; 1957 Dec; 113(1-2):148-56. PubMed ID: 13509779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rapid aggravation of bronze cirrhosis after a therapeutic trial with a chelating (EDTA calcium)].
    MARTY J; LESTAGE J
    Bull Mem Soc Med Hop Paris; 1958 Jan 10-17; 74(1-2):59-60. PubMed ID: 13511175
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of EDTA2Na in contrast media on hemodynamic and electrocardiographic changes during selective coronary angiography--an experimental study.
    Tanimoto Y
    Jpn Circ J; 1977 Sep; 41(9):999-1007. PubMed ID: 410964
    [No Abstract]   [Full Text] [Related]  

  • 7. [Temporary renal impairment during calcium EDTA treatment of lead poisoning].
    BOERSMA MJ; BEYER T
    Ned Tijdschr Geneeskd; 1960 Jun; 104():1152-4. PubMed ID: 13802058
    [No Abstract]   [Full Text] [Related]  

  • 8. [EDTA and cobalt poisoning].
    EYBL V; SYKORA J; KOCHER Z
    Cesk Fysiol; 1959 Jul; 8():331-2. PubMed ID: 13821123
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effect of intra-aortic injection of procaine against renal injuries produced in experimental aortography.
    HUGER WE; MARGOLIS G; GRIMSON KS
    Surgery; 1958 Jan; 43(1):52-62. PubMed ID: 13543579
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the kidney with the use of EDTA-Cr51].
    Efimov ON; Baĭchorov EO; Akimtseva NI; Pavlov BD
    Med Radiol (Mosk); 1971 Feb; 16(2):8-12. PubMed ID: 5006241
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adverse reactions to contrast media for magnetic resonance and echography].
    Simonetti G; Fanucci E; Masala S
    Radiol Med; 2004 Apr; 107(4 Suppl 1):34-5. PubMed ID: 15323320
    [No Abstract]   [Full Text] [Related]  

  • 12. Ventricular fibrillation during coronary angiography: reduced incidence in man with contrast media lacking calcium binding additives.
    Murdock DK; Johnson SA; Loeb HS; Scanlon PJ
    Cathet Cardiovasc Diagn; 1985; 11(2):153-9. PubMed ID: 3921258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal nephropathy during edathamil therapy in lead poisoning.
    BRUGSCH HG
    AMA Arch Ind Health; 1959 Oct; 20():285-92. PubMed ID: 13805211
    [No Abstract]   [Full Text] [Related]  

  • 14. Edetate kidney lesions in rats.
    REUBER MD; SCHMIELER GC
    Arch Environ Health; 1962 Nov; 5():430-6. PubMed ID: 13981800
    [No Abstract]   [Full Text] [Related]  

  • 15. Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats.
    Jost G; Pietsch H; Sommer J; Sandner P; Lengsfeld P; Seidensticker P; Lehr S; Hütter J; Sieber MA
    Invest Radiol; 2009 Feb; 44(2):114-23. PubMed ID: 19104440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of the EDTA lead-mobilization test.
    Wedeen RP; Batuman V; Landy E
    Environ Res; 1983 Feb; 30(1):58-62. PubMed ID: 6403349
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute kidney failure in lead poisoning; the role of EDTA].
    Tolot F; Prost G; Neulat G
    Nouv Presse Med; 1978 Oct; 7(36):3252-3. PubMed ID: 104277
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of inorganic lead poisoning with edathamil calcium-disodium.
    BELKNAP EL; PERRY MC
    AMA Arch Ind Health; 1954 Dec; 10(6):530-47. PubMed ID: 13206449
    [No Abstract]   [Full Text] [Related]  

  • 19. Chelation therapy in lead nephropathy questioned.
    Sawyer HJ
    Arch Intern Med; 1985 Oct; 145(10):1927. PubMed ID: 3929710
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chelating agents in vetrinary medicine].
    LE BARS H; MOLLE J
    Rev Pathol Gen Physiol Clin; 1958 Apr; 58(697):585-603. PubMed ID: 13579831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.